tradingkey.logo

Biogen rises after beating annual profit estimates

ReutersFeb 6, 2026 12:04 PM

Shares of drugmaker Biogen BIIB.O rise 1.26% to $187.69 premarket

Co sees 2026 adj. profit of $15.25-$16.25/shr, above Wall Street's estimate of $14.92

Reports Q4 adj. profit of $1.99/shr vs analysts' average estimate of $1.59/shr - LSEG data

Quarterly revenue $2.3 bln vs analysts' average expectation of $2.2 bln

Shares up ~15% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI